The case for clinical trials of tamoxifen for prevention of breast cancer

This publication has 16 references indexed in Scilit:

• Effects of Tamoxifen on Bone Mineral Density in Postmenopausal Women with Breast Cancer
  New England Journal of Medicine, 1992
• Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial. The Scottish Breast Cancer Committee.
  BMJ, 1991
• The development of a human cell line stably expressing human CYP3A4: role in the metabolic activation of aflatoxin B₁ and comparison to CYP1A2 and CYP2A3
  Carcinogenesis: Integrative Cancer Research, 1991
• Quantitative predictability of carcinogenicity of the covalent binding index of chemicals to DNA: comparison of the in vivo and in vitro assays.
  Environmental Health Perspectives, 1990
• Prevention of breast cancer with tamoxifen—an update on the royal Marsden Hospital pilot programme
  European Journal of Cancer and Clinical Oncology, 1990
• A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer
  British Journal of Cancer, 1989
• Combined oral contraceptives and liver cancer
  International Journal of Cancer, 1989
• ADJUVANT TAMOXIFEN IN EARLY BREAST CANCER: OCCURRENCE OF NEW PRIMARY CANCERS
  The Lancet, 1989
• THE PREVENTION OF BREAST CANCER
  The Lancet, 1986
• Effect of tamoxifen (ICI 46,474) on initiation and growth of DMBA-induced rat mammary carcinomata
  Published by Elsevier ,1976